The page below is a sample from the LabCE course Immune Hemolytic Anemias. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Immune Hemolytic Anemias (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 97 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

Drug-Induced Immune Hemolytic Anemia Introduction

Drug-induced immune hemolytic anemia is a rare category of autoimmune hemolytic anemias. Antibodies produced in response to a medication, or its metabolite, are the cause of the hemolytic anemia. The drug may cause a positive DAT, which may or may not be associated with immune hemolysis. Patients may present with similar serological and laboratory findings as the other types of autoimmune hemolytic anemias, and may be difficult to differentiate. Accurate medication history is beneficial in resolution of the serologic presentation.